Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial. - Liu Y; Zhang XY; Wei WS; Liu RQ; Pan QW; Zhang YJ; Li JB; Peng YL; Huang TX; Zhang ZL; Han H; Guo SJ; et al. (Cell reports. Medicine, 2026)